Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.
Several research groups have developed experimental vaccine approaches that protect nonhuman primates from Ebola virus and the closely related Marburg virus. These approaches include vaccines based on DNA, recombinant adenovirus, virus-like particles, and human parainfluenza virus 3. But how these vaccine candidates confer protection is an area that is still being explored: Do they activate immune cells to kill the invading virus? Or do they elicit antibodies that block infection?
In this study, scientists at NIH's National Institute of Allergy and Infectious Diseases and OHSU's Vaccine & Gene Therapy Institute built on earlier work with an experimental vaccine composed of an attenuated vesicular stomatitis virus carrying a gene that codes for an Ebola virus protein. They observed how cynomolgus macaques responded to a challenge of Ebola virus before and during treatment with the vaccine and in conjunction with depleted levels of immune cells. Their results showed that important immune cells—CD4+ T cells and CD8+ T cells—had a minimal role in providing protection, while antibodies induced by the vaccine appeared to be critical to protecting the animals.
The scientists say this finding will help improve future Ebola virus vaccine development. They plan to focus their studies on what level of antibody production is needed to establish protection from Ebola virus infection in humans
WHO: Heinz Feldmann, M.D., Ph.D., chief of the Laboratory of Virology at NIAID's Rocky Mountain Laboratories. Dr. Feldmann is an expert on viral hemorrhagic fevers and emerging viruses.
ARTICLE: A Marzi et al. Antibodies are necessary for rVSV/ZEBOV-GP mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.1209591110 (2013).
NIH/National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
The European Union's agreement to cut carbon dioxide emissions by 40 per cent by 2030 sounds impressive, but we're halfway to that already
The okapi is one of the worlds most elusive mammals. In 1904, the British explorer Percy Powell-Cotton set his sights on obtaining a specimen for his growing natural history collection. He succeeded and its skull is on display. But where is the rest of it?
Driven by the ongoing drought and the coming winter, bears are encroaching on Reno, Nevada in record numbers.
The UK's wind farms generated more power than its nuclear power stations on Tuesday, the National Grid says.
A charming and poetic account of apiculture in Mark Winston's Bee Time reminds us why an ancient partnership between humans and bees needs saving
Use of a cattle drug that has devastated vulture populations in India is in decline, offering hope of recovery – but vultures in Europe may now be at risk
The winners of the Society of Biology's third annual photography contest include amazing images of a haunting leopard, an otherworldly spider, and Yellowstone National Park's Grand Prismatic Spring.
Bee colonies in Brisbane are waging war for months on end, according to a new study, and the victorious swarms are taking over the hives of rival species.
Hundreds of thousands of cranes stop in Germany on their way to warmer climates
May, June, August and September have all been record-breaking months